Streetbeat News

Stock Prices

AMTX

Aemetis (NASDAQ:AMTX) is scheduled to release its quarterly earnings report on March 7, 2024, with an estimated EPS of $-0.34. Analysts and investors are keen on whether the company will surpass this estimate and provide positive guidance for the next quarter. Aemetis's stock performance has been generally positive over the last year, with a 12.23% increase, despite mixed past earnings performances.

Portfolio Pulse from Benzinga Insights

March 06, 2024 | 7:01 pm

ONCT

Oncternal Therapeutics (NASDAQ:ONCT) is scheduled to release its quarterly earnings report on March 7, 2024, with an expected EPS of $-3.07. Historical data shows a mixed reaction to past earnings, with the stock price fluctuating based on actual EPS outcomes and guidance provided. The company's stock has declined by 44.52% over the last year, indicating a bearish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

March 06, 2024 | 7:01 pm

EYPT

EyePoint Pharmaceuticals (NASDAQ:EYPT) is scheduled to release its quarterly earnings report on March 7, 2024, with analysts expecting an EPS of $-0.49. The company's past performance shows a mixed reaction to earnings reports, with the last quarter beating estimates by $0.18 and resulting in a 0.69% share price increase. Over the last year, EYPT shares have surged by 872.12%, indicating strong investor confidence. The upcoming earnings report and guidance will be crucial for future stock performance.

Portfolio Pulse from Benzinga Insights

March 06, 2024 | 7:01 pm

OPTN

OptiNose (NASDAQ:OPTN) is scheduled to release its quarterly earnings report on March 7, 2024, with an expected EPS of $-0.09. Analysts and investors are keen on not just the earnings beat but also the company's guidance for future growth. Historically, OptiNose has had a mixed performance in beating EPS estimates, with a notable increase in share price following last quarter's earnings beat. Shares have been trading at $1.725 as of March 5, showing a 1.72% increase over the last 52 weeks.

Portfolio Pulse from Benzinga Insights

March 06, 2024 | 7:01 pm

ELUT

Elutia (NASDAQ:ELUT) is scheduled to release its quarterly earnings report on March 7, 2024, with an estimated EPS of $-0.28. Analysts and investors are keen on whether Elutia will surpass this estimate and provide positive guidance for the next quarter. Historical data shows Elutia's stock price reacts significantly to earnings performance and guidance. Last quarter, Elutia beat the EPS estimate, resulting in an 11.64% stock price increase. Over the past year, Elutia's shares have declined by 14.36%.

Portfolio Pulse from Benzinga Insights

March 06, 2024 | 7:01 pm

DLTH

Duluth Holdings (NASDAQ:DLTH) is scheduled to release its quarterly earnings report on March 7, 2024, with an expected EPS of $0.27. Despite past earnings misses and a 36% decline in share price over the last year, investors are hopeful for positive guidance. Historical performance shows mixed reactions to earnings reports, with the stock price sometimes increasing despite misses.

Portfolio Pulse from Benzinga Insights

March 06, 2024 | 7:01 pm

CIEN

Ciena (NYSE:CIEN) is scheduled to release its quarterly earnings report on March 7, 2024, with analysts expecting an EPS of $0.47. Historical data shows mixed reactions to past earnings, with the last quarter beating estimates but resulting in a 4.23% share price drop. Shares have risen 26.65% over the last year, indicating positive sentiment among long-term investors.

Portfolio Pulse from Benzinga Insights

March 06, 2024 | 7:01 pm

CVX

Recent unusual options activity in Chevron (NYSE:CVX) indicates a bearish sentiment among deep-pocketed investors, with a significant volume of puts and calls suggesting a targeted price range of $140.0 to $180.0. The largest trades include both bearish and bullish sentiments, with notable trades in calls and puts. Chevron, a major integrated energy company, has seen its stock price increase by 0.95% to $151.01, with a neutral RSI and an upcoming earnings report in 51 days. An analyst from DZ Bank downgraded Chevron to Hold with a price target of $160.

Portfolio Pulse from Benzinga Insights

March 06, 2024 | 7:00 pm

EQIX

Recent unusual options activity in Equinix (NASDAQ:EQIX) shows a bullish stance by investors, with 69% of trades being bullish. Significant trades include both puts and calls with strike prices ranging from $800 to $980. Equinix operates 260 data centers globally and has a diverse customer base. The stock is currently up by 1.13%, priced at $905.69, but may be approaching overbought territory. Analysts have set an average price target of $714.4, with individual targets ranging from $781 to $950.

Portfolio Pulse from Benzinga Insights

March 06, 2024 | 7:00 pm

LII

Lennox Intl (NYSE:LII) received mixed analyst ratings, with an upward trend in 12-month price targets, now averaging $468.83, reflecting a 15.62% increase. Analysts from firms like TD Cowen, RBC Capital, and JP Morgan adjusted their ratings and price targets, indicating varying perspectives on the company's performance. Lennox Intl, a leader in HVAC and refrigeration, shows strong financial indicators such as a 5.58% revenue growth, a net margin of 12.51%, and an ROE of 64.97%, despite a high debt-to-equity ratio of 5.35.

Portfolio Pulse from Benzinga Insights

March 06, 2024 | 7:00 pm